544312 — Hamps Bio Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹106.72m
- IN₹136.40m
- IN₹66.69m
Annual cashflow statement for Hamps Bio, fiscal year end - March 31st, millions except per share.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | |
| Standards: | — | IAS | IAS | IAS | IAS |
| Status: | fx Preliminary | Final | Final | Final | Final |
| Net Income/Starting Line | — | 1.22 | 3.59 | 5.01 | 2.98 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | — | 1.87 | 1.73 | 2.48 | -8.88 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | — | -2.84 | 3.61 | -14.3 | -15.6 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | — | 3.33 | 12.3 | -2.92 | -17.7 |
| Capital Expenditures | — | -2.91 | -8.29 | -3.62 | -37.2 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | 7.99 | 0.799 | -0.049 | -24.8 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | — | 5.08 | -7.49 | -3.67 | -62 |
| Financing Cash Flow Items | — | -1.9 | -1.77 | -1.5 | -1.4 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | — | -9.44 | -4.83 | 6.68 | 80 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | — | -1.03 | -0.024 | 0.095 | 0.373 |